Stefan Haider
Angestellt, Associate Director Upstream Development, Boehringer Ingelheim RCV GmbH & Co KG
Vienna, Österreich
Werdegang
Berufserfahrung von Stefan Haider
Bis heute 3 Jahre und 4 Monate, seit Feb. 2021
Lecturer
IMC FH Krems
Medical & Pharmaceutical Biotechnology -Downstream Processing -Pharmaceutical Protein Production Systems
Bis heute 3 Jahre und 5 Monate, seit Jan. 2021
Associate Director Upstream Development
Boehringer Ingelheim RCV GmbH & Co KGResponsible for the development, scale-up and transfer of biopharmaceutical production processes for BI's NBEs as well as for client projects to clinical and commercial scale facilities. Leading & coaching matrix leaders in DS process development (focus USP development). Coordination of the project portfolio in upstream development for NBE &client projects including management of allocated resources. Continuous improvement of the groups capabilities by introducing new technologies and new ways of working.
2 Jahre und 3 Monate, Okt. 2018 - Dez. 2020
Associate Director Upstream Development NBE & Biosimilars
Boehringer Ingelheim RCV GmbH & Co KGResponsible for the development, scale-up and transfer of biopharmaceutical production processes for BI's NBE & biosimilar projects to clinical and commercial scale facilities. Lab head of a microbial upstream development group consisting of scientific and technical staff. Coordination of lab work as well as NBE & Biosimilar project portfolio in upstream development. Business project manager & SC member for the deployment and implementation of the InCyght fermentation data analysis software (PAS-X Savvy).
4 Jahre und 4 Monate, Juni 2014 - Sep. 2018
Scientist Downstream Development NBE and Biosimilars
Boehringer Ingelheim RCV GmbH & Co KGBiopharmaceuticals / Process Science - Downstream Development I Downstream development of NBEs and biosimilars at bench scale, support of up-scaling and facility fitting. Team member in cross-project panels, continuous improvement initiatives and technology development platforms. Principal investigator in joint research projects with the Austrian Center for Industrial Biotechnology.
1 Jahr und 3 Monate, März 2013 - Mai 2014
Supervisor R&D
Baxter BioScience
Biologics R&D / Drug Development - Protein Modification Coordination of development activities in late-stage projects and lead of a small R&D team focusing on product- and process-related analytics.
2 Jahre und 2 Monate, Jan. 2011 - Feb. 2013
Research Scientist
Baxter BioScience
Global Biologics Research / Drug Development - Protein Modification Shift of responsibilities from early developments to late stage product development to support transitioning the drug candidates into clinical testing and ultimately to operations (longer-acting ADVATE® follow-ups). Key focuses: Trouble shootings and root cause analyses of critical process steps. Facilitation and coordination of QbD projects and studies.
2 Jahre und 11 Monate, Feb. 2008 - Dez. 2010
PhD Student / Product- & Process Engineer
Baxter BioScience
Hemophilia, Exploratory & Preclinical R&D - Protein Modification Development of novel strategies for the chemical modification of blood coagulation factors (FIX, FVIII, FVIIa) with polymeric substances. Responsibility for reaction design and optimization, establishment of suitable preparative purification techniques for the drug candidates as well as for the product- and process-related analytics.
4 Monate, Okt. 2007 - Jan. 2008
Tutor
FH Krems
Institute of Medical & Pharmaceutical Biotechnology Supervising and supporting students in the bioprocess technology lab.
Biopharmaceutical Operations / Process Science - Downstream Responsible for the development of a generic process for the epsilon-amino-PEGylation of therapeutic peptides. Key focuses: a) the investigation of the conjugation reaction by applying principles of DoE in order to obtain a mechanistic view of the reaction progress; b) the development of chromatographic purification techniques for the resulting conjugates; and c) the analytical characterization of the conjugates.
Ausbildung von Stefan Haider
4 Jahre und 8 Monate, Okt. 2006 - Mai 2011
Technical Chemistry
Technische Universität Wien
Chemical Engineering / Dissertation: "N-Glycan Modification of Recombinant Factor IX - A Novel Approach for the Polysialylation of Therapeutic Proteins"
3 Jahre und 9 Monate, Okt. 2002 - Juni 2006
Medical & Pharmaceutical Biotechnology
IMC Krems, University of Applied Sciences
Diploma thesis: "Characterization of monoPEGylated alpha-Lactalbumin"
Sprachen
Englisch
Fließend
Deutsch
Muttersprache